NCT04967781View on ClinicalTrials.gov

Autoimmunity Contributes to the Severe Progression of COVID-19

CompletedOBSERVATIONAL
Enrollment

162

Participants

Timeline

Start Date

March 10, 2020

Primary Completion Date

May 27, 2021

Study Completion Date

May 27, 2021

Conditions
Coronavirus Disease 2019
Interventions
BEHAVIORAL

autoimmunity

autoimmunity is characterized as self attacking from self immune system, which may involve in the severe progression of COVID-19.

Trial Locations (1)

430000

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER

NCT04967781 - Autoimmunity Contributes to the Severe Progression of COVID-19 | Biotech Hunter | Biotech Hunter